Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

NCT07163845 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

5354

Enrollment

INDUSTRY

Sponsor class

Conditions

Chikungunya Virus Infection

Interventions

BIOLOGICAL: Live-attenuated CHIKV vaccine VLA1553

Sponsor

Valneva Austria GmbH

Collaborators

[object Object]
[object Object]